Oncology nursing plays a pivotal role in cancer research by providing compassionate care and invaluable support to patients undergoing treatment. These specialized nurses possess a deep understanding of cancer biology, treatment modalities, and symptom management. They serve as crucial liaisons between patients and multidisciplinary healthcare teams, ensuring comprehensive care delivery and optimal outcomes.
In the realm of cancer research, oncology nurses often participate in clinical trials, assisting in data collection, patient education, and adherence to protocols. Their frontline perspective offers invaluable insights into treatment efficacy, side effects, and patient experiences, contributing to the refinement of therapies and improvement of patient care standards. Moreover, oncology nurses engage in community outreach and education initiatives, raising awareness about prevention, early detection, and available resources, thereby empowering individuals to take proactive steps in their health journey.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China